Global Cell Dissociation Market Size Study by Tissue (Connective Tissue, Epithelial Tissue, Other Tissue), By Type (Tissue Dissociation, Cell Detachment), By End User (Pharmaceutical & Biotechnological Companies, Research & Academic Institutes, Other End Users), and Regional Forecasts 2017-2025

June 2018 | 120 pages | ID: GB107A7C72BEN
Bizwit Research & Consulting LLP

Abstracts

Global Cell Dissociation Market to reach USD 575 million by 2025.

Global Cell Dissociation Market valued approximately USD 189,9 million in 2016 is anticipated to grow with a healthy growth rate of more than 13.1% over the forecast period 2017-2025. Factors that are the driving force for growth of this market include rising government funding for chronic disease research and increasing R&D investment in pharmaceutical & biotechnology companies. On the other hand, emerging economies such as China, India, and Brazil are providing ample of opportunities for the players operating in cell dissociation market.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Tissue:

• Connective Tissue
• Epithelial Tissue
• Other Tissue

By Type:

• Tissue Dissociation
• Cell Detachment

By End User:

• Pharmaceutical & Biotechnological Companies
• Research & Academic Institutes
• Other End Users

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are ATCC, BD, F. Hoffmann-La Roche Ltd, GE Healthcare, HI media Laboratories, Merck KGAA, Miltenyi Biotec, Pan-Biotech, Stem cell Technologies, Thermo Fisher Scientific. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Cell Dissociation in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. GLOBAL CELL DISSOCIATION MARKET DEFINITION AND SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL CELL DISSOCIATION MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL CELL DISSOCIATION MARKET, BY TISSUES

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Cell Dissociation Market, Sub Segment Analysis
  5.3.1. Connective Tissue
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.2. Epithelial Dissociation
    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.3. Other Tissues
    5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. GLOBAL CELL DISSOCIATION MARKET, BY TYPE

6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Cell Dissociation Market, Sub Segment Analysis
  6.3.1. Tissue Dissociation
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.2. Cell Detachment
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. GLOBAL CELL DISSOCIATION MARKET, BY END-USER

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Cell Dissociation Market, Sub Segment Analysis
  7.1.1. Pharmaceutical & Biotechnological Companies
    7.1.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.1.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.1.2. Research & Academic Institutes
    7.1.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.1.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.1.3. Other End-Users
    7.1.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.1.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. GLOBAL CELL DISSOCIATION MARKET, BY REGIONAL ANALYSIS

8.1. Cell Dissociation Market, Regional Market Snapshot (2015-2025)
8.2. North America Cell Dissociation Market Snapshot
  8.2.1. U.S.
    8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.2.2. Canada
    8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Cell Dissociation Market Snapshot
  8.3.1. U.K.
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.2. Germany
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.3. France
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.4. Rest of Europe
    8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Cell Dissociation Market Snapshot
  8.4.1. China
    8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.2. India
    8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.3. Japan
    8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.4. Rest of Asia Pacific
    8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5. Rest of The World
  8.5.1. South America
    8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.5.2. Middle East and Africa
    8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.2. Tissue breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.3. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
  9.3.1. ATCC
    9.3.1.1. Overview
    9.3.1.2. Financial (Subject to Data Availability)
    9.3.1.3. Product Summary
    9.3.1.4. Recent Developments
  9.3.2. BD
  9.3.3. F. Hoffmann-La Roche Ltd.
  9.3.4. GE Healthcare
  9.3.5. Himedia Laboratories
  9.3.6. Merck KGAA
  9.3.7. Miltenyi Biotec
  9.3.8. Pan-Biotech
  9.3.9. Stemcell Technologies
  9.3.10. Thermo Fisher Scientific